Long-term use of proton pump inhibitors
Pro Research Analysisby 
Searched over 200M research papers
Long-Term Proton Pump Inhibitor Use: Safety and Adverse Effects
Effectiveness and Indications for Long-Term PPI Use
Proton pump inhibitors (PPIs) are highly effective for treating acid-related disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and for preventing ulcers in high-risk patients, especially those on NSAIDs or with Helicobacter pylori infection 13610. However, many patients continue PPI therapy for extended periods without a clear medical indication, which increases unnecessary exposure to potential risks 457.
Common Adverse Effects of Long-Term PPI Use
Mineral and Micronutrient Deficiencies
Long-term PPI use has been linked to deficiencies in magnesium, calcium, iron, and vitamin B12, particularly in elderly patients or those on high doses 1468+2 MORE. These deficiencies can lead to conditions such as hypomagnesemia, hypocalcemia, anemia, and osteoporosis 4810.
Increased Risk of Infections
PPIs can alter stomach acidity, which may increase the risk of certain infections. Studies have shown a higher risk of community-acquired pneumonia and, to a lesser extent, Clostridium difficile infection in long-term users 1236+1 MORE. However, the evidence for C. difficile infection is less consistent, especially in community settings 1410.
Bone Fractures and Bone Health
There is some concern that long-term PPI use may be associated with an increased risk of bone fractures due to impaired calcium absorption and possible effects on bone mineralization 2346+2 MORE. However, the data are mixed, and not all studies confirm a significant risk .
Kidney Disease
Recent research suggests a possible link between prolonged PPI use and chronic kidney disease, including acute interstitial nephritis and progression to end-stage renal disease 36810. This risk highlights the importance of monitoring kidney function in long-term users.
Cardiovascular and Cognitive Risks
Some observational studies have reported associations between long-term PPI use and increased risks of major cardiovascular events and dementia, though the evidence is not definitive and more high-quality studies are needed 3610.
Gastric Changes and Cancer Risk
Long-term PPI therapy can cause fundic gland polyps, which often regress after stopping the medication 126. There is ongoing debate about whether PPIs contribute to gastric atrophy, enterochromaffin-like (ECL) cell hyperplasia, or gastric cancer, especially in the presence of H. pylori infection, but current evidence does not conclusively prove a direct link 1267.
Overuse and Deprescribing
A significant proportion of long-term PPI users do not have a clear ongoing indication for therapy 457. On-demand or intermittent therapy is often more cost-effective and may reduce unnecessary risks 5710. Guidelines recommend regular reassessment of the need for continued PPI use and deprescribing when appropriate .
Conclusion
PPIs are generally safe and effective when used for appropriate indications, but long-term use can be associated with several adverse effects, including mineral deficiencies, infections, bone fractures, kidney disease, and possibly cardiovascular and cognitive risks. Many patients remain on PPIs without a clear need, exposing them to unnecessary risks. Regular review of therapy, monitoring for adverse effects, and deprescribing when possible are essential to ensure safe long-term use of PPIs 1345+5 MORE.
Sources and full results
Most relevant research papers on this topic
Safety of the long-term use of proton pump inhibitors.
Long-term use of proton pump inhibitors (PPIs) is remarkably safe and effective for treating peptic ulcer disorders, with rare serious adverse events and potential risks of vitamin B12 deficiencies and Clostridium difficile-associated diarrhea.
Potential problems of long-term use of proton pump inhibitors
Long-term use of proton pump inhibitors (PPIs) may cause potential problems, including pneumonia, Clostridium difficile infection, bone fracture, malabsorption, cognitive impairment, and even gastric cancer.
DOI